3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Completed
9
Recruiting
8
Withdrawn
2
Terminated
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Pancreatic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Rectal Neoplasms
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Neoplasms
5
Glioblastoma
5
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Stomach Neoplasms
3
Oligodendroglioma
3
Mouth Neoplasms
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Astrocytoma
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Meningioma
2
Melanoma
2
Gliosarcoma
2
Glioma, Subependymal
2
Fallopian Tube Neoplasms
2
Ependymoma
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Interventions
Doxorubicin
13
Gemcitabine
10
Cyclophosphamide
10
pazopanib
8
Filgrastim
8
Radiotherapy
7
Ifosfamide
7
Cisplatin
7
Irinotecan
6
Docetaxel
6
Radiation
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Trabectedin
4
Magnetic Resonance Spectroscopy
4
Celecoxib
4
Busulfan
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
temsirolimus
3
sargramostim
3
pembrolizumab
3
X-Rays
3
Sirolimus
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Neoadjuvant Therapy
3
Leucovorin
3
Dexrazoxane
3
Cryosurgery
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Sarcoma
×
Surgical Procedures, Operative
×
Clear all
NCT03116529
2024-11-04
NEXIS
University of Maryland, Baltimore
Phase 1/2
Terminated
22 enrolled
NCT00901836
2017-02-10
SA03
University of Florida
Phase NA
Terminated
2 enrolled